Samuelov Liat, Kinori Michael, Chamlin Sarah L, Wagner Annette, Kenner-Bell Brandi M, Paller Amy S, Kruse Lacey L, Mancini Anthony J
Division of Dermatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Pediatr Dermatol. 2018 May;35(3):329-335. doi: 10.1111/pde.13437. Epub 2018 Feb 28.
BACKGROUND/OBJECTIVES: Cutaneous juvenile xanthogranuloma is an uncommon, usually benign disease affecting infants and young children. Ocular and other systemic involvement have been reported, but their incidence is unclear, and the utility of routine screening is not well established. Our aim was to characterize the risk of ocular and systemic complications in children with cutaneous juvenile xanthogranuloma.
In this retrospective study, we reviewed the medical charts of children with cutaneous juvenile xanthogranuloma seen at Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, between January 2000 and December 2015. A comprehensive literature review was also performed.
Of 338 children with cutaneous juvenile xanthogranuloma, 76 (median age 6 months, 51% female) met inclusion criteria. The most frequently involved site was the head and neck region (40%). In 39 patients (51%), there was a single lesion. Multiple lesions (>5) were evident in 20 patients (26%). Most cutaneous juvenile xanthogranulomas were micronodular (77%). None of the patients had ocular involvement. One patient had multiple asymptomatic hepatic nodules on imaging that regressed spontaneously within several months. Literature review of pediatric cutaneous juvenile xanthogranuloma series, including our cohort, revealed that the incidence of ocular manifestations is 0.24% (7/2949) and of systemic manifestations is 0.75% (22/2949).
Cutaneous juvenile xanthogranulomas are generally limited to the skin. Because eye involvement is rare, a routine eye examination is of low yield and probably not warranted in children with no ocular or visual symptoms. New recommendations for systemic screening could not be drawn from this study.
背景/目的:皮肤幼年性黄色肉芽肿是一种罕见的、通常为良性的疾病,影响婴幼儿。眼部及其他全身受累情况已有报道,但其发生率尚不清楚,常规筛查的作用也未得到充分证实。我们的目的是明确皮肤幼年性黄色肉芽肿患儿眼部及全身并发症的风险。
在这项回顾性研究中,我们查阅了2000年1月至2015年12月期间在伊利诺伊州芝加哥安和罗伯特·H·卢里儿童医院就诊的皮肤幼年性黄色肉芽肿患儿的病历。同时还进行了全面的文献综述。
338例皮肤幼年性黄色肉芽肿患儿中,76例(中位年龄6个月,51%为女性)符合纳入标准。最常受累部位是头颈部(40%)。39例患者(51%)有单个病灶。20例患者(26%)有多个病灶(>5个)。大多数皮肤幼年性黄色肉芽肿为微小结节状(77%)。所有患者均无眼部受累。1例患者影像学检查发现多个无症状肝脏结节,数月内自行消退。对包括我们队列在内的儿童皮肤幼年性黄色肉芽肿系列文献综述显示,眼部表现的发生率为0.24%(7/2949),全身表现的发生率为0.75%(22/2949)。
皮肤幼年性黄色肉芽肿通常局限于皮肤。由于眼部受累罕见,对于无眼部或视觉症状的儿童,常规眼部检查收益较低,可能没有必要。本研究无法得出关于全身筛查的新建议。